✦ LIBER ✦

Phase I trial results of a folate receptor alpha-directed cancer vaccine (E39) in ovarian and endometrial cancer patients to prevent recurrence

✍ Scribed by Byrd, K.A.; Schneble, E.; Ponniah, S.; McGuire, W.P.; Conrads, T.P.; Elkas, J.C.; Darcy, K.M.; Maxwell, G.L.; Hamilton, C.A.; Peoples, G.

Book ID: 127334482
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 121 KB
Volume: 133
Category: Article
ISSN: 0090-8258
DOI: 10.1016/j.ygyno.2014.03.118

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Preliminary results for the phase 1 tria

Preliminary results for the phase 1 trial of a folate receptor alpha adjuvant cancer vaccine in ovarian and endometrial cancer patients

✍ John S Berry,Erika J Schneble,Alfred F Trappey… 📂 Article 📅 2013 🏛 Springer (Biomed Central Ltd.) 🌐 English ⚖ 65 KB

Clinical trial results of the HER-2/neu

Clinical trial results of the HER-2/neu (E75) vaccine to prevent breast cancer recurrence in high-risk patients : From US Military Cancer Institute Clinical Trials Group Study I-01 and I-02

✍ Elizabeth A. Mittendorf; Guy T. Clifton; Jarrod P. Holmes; Kevin S. Clive; Rites 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 1016 KB

Final report of the phase I/II clinical

Final report of the phase I/II clinical trial of the E75 (nelipepimut-S) vaccine with booster inoculations to prevent disease recurrence in high-risk breast cancer patients

✍ Mittendorf, E. A.; Clifton, G. T.; Holmes, J. P.; Schneble, E.; van Echo, D.; Po 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 277 KB

Optimized sequence of drug administratio

Optimized sequence of drug administration and schedule leads to improved dose delivery for gemcitabine and paclitaxel in combination: a phase I trial in patients with recurrent ovarian cancer

✍ C.J. POOLE; T. PERREN; S. GAWANDE; M. RIDDERHEIM; J. COOK; A. JENKINS; D. ROYCHO 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB

Addition of interferon-α to the p53-SLP®

Addition of interferon-α to the p53-SLP® vaccine results in increased production of interferon-γ in vaccinated colorectal cancer patients: A phase I/II clinical trial

✍ Zeestraten, Eliane C.M.; Speetjens, Frank M.; Welters, Marij J.P.; Saadatmand, S 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 French ⚖ 611 KB

1771 TREATMENT WITH INTRACUTANEOUS AND I

1771 TREATMENT WITH INTRACUTANEOUS AND INTRAVESICAL KEYHOLE LIMPET HEMOCYANIN IS INFERIOR TO INTRAVESICAL MITOMYCIN-C FOR PREVENTION OF RECURRENCES IN PATIENTS WITH NON-MUSCLE-INVASIVE BLADDER CANCER: RESULTS FROM A PROSPECTIVE RANDOMIZED PHASE III TRIAL

✍ Lammers, Rianne J.M.; Witjes, Wim P.J.; Janzing-Pastors, Maria H.C.; Caris, Chri 📂 Article 📅 2012 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 121 KB